2022
DOI: 10.1111/hae.14507
|View full text |Cite
|
Sign up to set email alerts
|

Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres

Abstract: Background: Data are limited on prostate cancer (PC) management in patients with haemophilia (PWH). Aim: To describe PC screening and diagnosis, treatment modalities and bleeding complications in a group of unselected PWH followed at French Haemophilia Treatment Centres (HTCs) Patients and methods: PC screening, management and bleeding complications were retrospectively investigated at 14 French HTCs between 2003 and 2018. Results: Among> 1549 > 50-year-old PWHs, 73 (4.7%) underwent PC screening (median age 71… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
5
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(5 citation statements)
references
References 28 publications
(73 reference statements)
0
5
0
Order By: Relevance
“…The paper by Gautier and colleagues from 14 French haemophilia centres describing in the current issue of Haemophilia their questionnaire‐based survey is timely 5 . It reports the management of 86 PWH undergoing prostate biopsies and that of cancer in 50 older individuals between 2003 and 2018 (age range 56–87), 28 of them treated with surgery and the remaining 22 with other modalities.…”
mentioning
confidence: 99%
See 4 more Smart Citations
“…The paper by Gautier and colleagues from 14 French haemophilia centres describing in the current issue of Haemophilia their questionnaire‐based survey is timely 5 . It reports the management of 86 PWH undergoing prostate biopsies and that of cancer in 50 older individuals between 2003 and 2018 (age range 56–87), 28 of them treated with surgery and the remaining 22 with other modalities.…”
mentioning
confidence: 99%
“…Regarding the management of cancer surgery, the median time interval between objective diagnosis and treatment was as long as 3 months, even though the majority of cancers were fortunately localized (90%). 5 This unduly long post-diagnosis interval is perhaps due to poor experience with a rare disease such as haemophilia by the urologists and thus some degree of hesitancy. As expected for such a major surgical procedure all patients, irrespective of the severity of haemophilia, were prophylactically treated with factor concentrates for a much longer period than biopsy (median of 16 days for severe/moderate haemophilia and 10 for mild hemophilia A).…”
mentioning
confidence: 99%
See 3 more Smart Citations